Notes - Segment Information, Etc.

Immuno-Biological Laboratories Co., Ltd. - Filing #7325711

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
812,850,000 JPY
816,701,000 JPY
3,851,000 JPY
816,701,000 JPY
JPY
794,621,000 JPY
790,600,000 JPY
JPY
4,021,000 JPY
794,621,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
2,333,000 JPY
2,333,000 JPY
JPY
2,333,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
Increase in property, plant and equipment and intangible assets
21,768,000 JPY
21,768,000 JPY
JPY
21,768,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.